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Abstract
Objective To describe one year outcomes for a national cohort of infants
with gastroschisis.
Design Population based cohort study of all liveborn infants with
gastroschisis born in the United Kingdom and Ireland from October 2006
to March 2008.
Setting All 28 paediatric surgical centres in the UK and Ireland.
Participants 301 infants (77%) from an original cohort of 393.
Main outcome measures Duration of parenteral nutrition and stay in
hospital; time to establish full enteral feeding; rates of intestinal failure,
liver disease associated with intestinal failure, unplanned reoperation;
case fatality.
Results Compared with infants with simple gastroschisis (intact,
uncompromised, continuous bowel), those with complex gastroschisis
(bowel perforation, necrosis, or atresia) took longer to reach full enteral
feeding (median difference 21 days, 95% confidence interval 9 to 39
days); required a longer duration of parenteral nutrition (median
difference 25 days, 9 to 46 days) and a longer stay in hospital (median
difference 57 days, 29 to 95 days); were more likely to develop intestinal
failure (81% (25 infants) v 41% (102); relative risk 1.96, 1.56 to 2.46)
and liver disease associated with intestinal failure (23% (7) v 4% (11);
5.13, 2.15 to 12.3); and were more likely to require unplanned reoperation
(42% (13) v 10% (24); 4.39, 2.50 to 7.70). Compared with infants
managed with primary fascial closure, those managed with preformed
silos took longer to reach full enteral feeding (median difference 5 days,
1 to 9) and had an increased risk of intestinal failure (52% (50) v 32%
(38); 1.61, 1.17 to 2.24). Event rates for the other outcomes were low,
and there were no other significant differences between these
management groups. Twelve infants died (4%).
Conclusions This nationally representative study provides a benchmark
against which individual centres can measure outcome and performance.
Stratifying neonates with gastroschisis into simple and complex groups
reliably predicts outcome at one year. There is sufficient clinical equipoise
concerning the initial management strategy to embark on a multicentre
randomised controlled trial comparing primary fascial closure with
preformed silos in infants suitable at presentation for either treatment to
determine the optimal initial management strategy and define algorithms
of care.
Introduction
The birth prevalence of gastroschisis in the United Kingdom
1 2
and worldwide
3-5 has increased steadily over the past few
decades, with considerable financial and resource implications
for healthcare providers.
6 Advances in neonatal intensive care
andthedevelopmentofparenteralnutritionhavereducedinfant
mortality rates for gastroschisis from 60% in the 1960s
7 to
3-10%inthemid-1990s,
8-10withnoclearevidenceofareduction
in mortality since then.
3 Attempts have been made to stratify
neonates with gastroschisis into high and low risk groups to
assess outcomes of more individualised approaches to
management.
11-16
Surgical strategies for gastroschisis have evolved but with
limited evidence and no consensus on the optimal initial
management or an effective clinical pathway. The techniques
forreducingthevisceraandclosingthedefectconsistofprimary
or staged and operative or non-operative techniques, based on
the requirement or otherwise for a silo and general anaesthetic,
respectively.Recognitionofthelinkbetweenvisceroabdominal
disproportion and intra-abdominal hypertension after operative
primary fascial closure led to the development of operative
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Research
RESEARCHstagedapproachesinthe1960s,usingvarioussyntheticmaterials
to gradually reduce the viscera.
17 This led to an era of
“individualised” management with operative staged reduction
reserved for neonates with severe visceroabdominal
disproportion in whom reduction and operative primary fascial
closure was deemed unsafe.
18 The development of preformed
silastic silos in the early 1990s
19 has changed the management
of gastroschisis to the point where routine placement of the silo
at the cotside,
20 without the need for a general anaesthetic and
surgery on the first day of life, has been adopted by some
surgeons as the initial intended strategy.
15 20 This approach has
been increasingly used in the UK, whereas primary reduction
of the viscera at the cotside,
16 while done in selected cases, is
lesswidelyperformed.
21Thesemethodsarebothindividualised
approacheswithselectioncriteriainthattheyarenotappropriate
with perforated or gangrenous bowel or atresia suitable for
immediate anastomosis.
22 23
Information regarding operative outcomes for contemporary
surgical techniques in gastroschisis, however, is still primarily
limited to retrospective case series
24-26 collected over prolonged
periods of time at single referral centres. To date there has been
onlyoneotherprospectivepopulationbasedobservationalstudy
of gastroschisis to provide representative outcome data in a
cohortofneonatesbornduringthesameshorttimeperiod,
27but
thisprovidesonlyshorttermfollow-updatatodeathorhospital
discharge. We described outcomes at one year for a national
cohortofinfantswithgastroschisis,identifiedthroughtheBritish
Association of Paediatric Surgeons Congenital Anomalies
Surveillance System (BAPS-CASS).
Methods
We identified a national cohort of liveborn infants presenting
with gastroschisis from October 2006 to March 2008 through
BAPS-CASS.
21 Each month we sent a routine reporting card to
nominated reporting clinicians in all paediatric surgical units
intheUKandIreland,requestingdetailsofthenumberofinfants
born and admitted to their unit that month with gastroschisis.
In response to a monthly card return indicating that there had
beenacaseofgastroschisis,wesentcliniciansaformrequesting
further details including diagnosis, surgical management,
operativecomplications,andotheroutcomesuptofirstdischarge
fromhospitalorsixmonthsofage,whichevercamesooner.We
maximised case ascertainment by using the UK Obstetric
Surveillance System (UKOSS) and the British Isles Network
of Congenital Anomalies Registers (BINOCAR) as secondary
sources of cases.
28 29 A second form was sent when each child
wasaged1yearrequestingfurtherdetailsofoutcomesincluding
of enteral feeding, duration of stay in hospital, unplanned
reoperations, delayed complications, and mortality. Up to three
reminders were sent if the first form was not returned.
Statistical analyses
Outcomeswereexploredinprespecifiedsubgroups.Specifically,
we looked at outcomes in infants with simple gastroschisis
(defined as intact continuous bowel that is not compromised or
breached at delivery or presentation) compared with those with
complex gastroschisis (defined as the presence of one or more
of intestinal atresia, perforation or intestinal necrosis at delivery
or presentation, or missed atresia).
14 Outcomes in infants with
simple gastroschisis initially managed with operative primary
fascialclosureorpreformedsiloplacementwerealsocompared
with Fisher’s exact test, χ
2 test, and Wilcoxon-Mann-Whitney
U test as appropriate for non-parametric data. Groups were
classified according to their initial management—that is, first
planned management strategy—thus some infants in the
operative primary fascial closure group were subsequently
managed with a preformed silo and vice versa.
21 Median
differences for non-normally distributed data were calculated
with Hodges-Lehmann estimates of shift parameters. The
outcomes of primary interest were duration of parenteral
nutrition, time to full enteral feeding, rates of intestinal failure,
liverdiseaseassociatedwithintestinalfailure,andcasefatality.
For the purposes of this study we defined intestinal failure as a
requirement for more than 28 days of parenteral nutrition,
30 and
liver disease associated with intestinal failure as liver
dysfunction(cholestasisinassociationwithraisedserumalkaline
phosphatase and total bilirubin concentrations) in infants
receiving parenteral nutrition. We calculated relative risks with
95% confidence intervals, using the ratio of the proportion of
each outcome in one group to the proportion in the comparator
group. Analyses were performed with SPSS version 15 (SPSS,
Chicago,IL)orSTATAversion10(StataCorp,CollegeStation,
TX), or R version 2.13.1 (R Project for Statistical Computing).
Results
Birth data were received for 393 infants with gastroschisis in a
birth cohort of 1.1 million. Information about follow-up at the
age of 1 year or death (whichever occurred first) was available
for 301 infants (77%) (figure⇓). Table 1⇓ shows the
characteristics of infants with follow-up at 1 year compared
withinfantsforwhomonlyinitialdatawereavailable.Aslightly
higher (but non-significant) proportion of the infants with
follow-up data were initially managed with a preformed silo,
and a significantly higher proportion were transferred between
hospitalsafterbirth.Therewerenoothersignificantdifferences
between the groups with and without 1 year follow-up data.
Outcomes for simple and complex
gastroschisis
There were no significant differences in the demographic and
clinical characteristics listed in table 1 of infants with simple
or complex gastroschisis with follow-up data. Table 2 shows
theoutcomesforinfantswithsimpleandcomplexgastroschisis⇓.
Sevencaseshadinsufficientinformationtoenableclassification
into complex or simple and have been excluded. Infants with
complex gastroschisis took longer to reach full enteral feeding
(median difference 21 days, 95% confidence interval 9 to 39
days) and were more likely to develop intestinal failure and
liver disease associated with intestinal failure. Infants with
complex gastroschisis were also more likely to require
unplanned reoperation and a prolonged stay in hospital. The
median length of stay was 84 days (interquartile range (IQR)
47-197, range 20-365) for infants with complex gastroschisis
and 36 days (IQR 23-57, range 8-365) for those with simple
gastroschisis (including four infants (three simple and one
complex)stillinhospitalattheageof1year)(mediandifference
57 days, 29 to 95 days; P<0.001). The median duration of
parenteral nutrition was 51 days (IQR 29-92, range 9-297) for
infants with complex gastroschisis and 23 days (IQR 16-38,
range 2-365) for those with simple gastroschisis (including two
infants still receiving parenteral nutrition at 1 year of age)
(median difference 25 days, 9 to 46 days; P<0.001).
Outcomes for primary fascial closure and
preformed silo in simple gastroschisis
Thetwomostcommonlyperformedinitialproceduresforsimple
gastroschisis in the UK are primary operative primary fascial
closureandapplicationofapreformedsilowithdelayedfascial
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21 There were no significant differences in the
demographic and clinical characteristics listed in table 1 of
infantswithsimplegastroschisismanagedwiththeseprocedures
and with follow-up data, with the exception of the proportion
transferred after birth. A higher proportion of infants managed
with a preformed silo were transferred: 55% (62) compared
with 28% (39) managed with operative primary fascial closure.
Table 3 shows the outcomes at 1 year for these procedures in
neonates with simple gastroschisis⇓. Infants managed with
applicationofapreformedsilotooksignificantlylongertoreach
fullenteralfeeding(mediandifference5days,1to9days),were
significantly more likely to develop intestinal failure, and had
a tendency to stay longer in hospital. The median duration of
parenteral nutrition was 20 days (IQR 14-34, range 2->365) for
infantsmanagedinitiallywithoperativeprimaryfascialclosure
and 29 days (IQR 9-41, range 2->365) for those managed with
apreformedsilo(mediandifference5days,1to9days;P=0.02)
(includes one infant in each group still receiving parenteral
nutrition at one year). The median length of stay was 34 days
(IQR 23-51, range 12->365) for infants managed initially with
operative primary fascial closure (includes two infants still in
hospitalat1yearofage)and38days(IQR26-65,range8->365)
for those managed with a preformed silo (includes one infant
stillinhospitalat1yearofage)(mediandifference4dayslonger
in the preformed silo group, 2 days shorter to 10 days longer;
P=0.08). Event rates in the other outcomes were low, and there
were no other significant differences in any of the outcomes we
examined.
Mortality
There were six deaths in the neonatal period and six in the
post-neonatal period. All the neonatal deaths occurred in the
simple gastroschisis group, with three infants dying from
ischaemic bowel after initial management with a preformed or
custom silo. The other neonatal deaths were from causes
unrelatedtothegastroschisis.Twoinfantsdiedfromnecrotising
enterocolitis in the second month after birth, two infants died
from sepsis, and two died from liver failure before 1 year of
age. The overall case fatality was 4% (12/302, 2% to 7%). The
case fatality for the complex and simple groups was 3% (0% to
17%) and 4% (2% to 8%), respectively.
Discussion
Principal findings
Infantswithcomplexgastroschisisaresignificantlymorelikely
to develop intestinal failure and liver disease associated with
intestinal failure compared with infants with simple
gastroschisis.Theyalsotaketwiceaslongtoachievefullenteral
feeding (47 versus 24 days, respectively). In addition, infants
with complex gastroschisis are more likely to require an
unplanned reoperation and a prolonged stay in hospital.
Thetwomostcommonlyperformedinitialproceduresforsimple
gastroschisis in the UK are either operative primary fascial
closure or application of a preformed silo with delayed fascial
closure.
21Theresultsofournationalobservationalstudysuggest
thatinfantswithsimplegastroschisismanagedwithapreformed
silo take longer to reach full enteral feeding and are more likely
todevelopintestinalfailure.Therewasnosignificantdifference
between the groups in the proportion of infants going on to
developliverdiseaseassociatedwithintestinalfailure(operative
primary fascial closure 4% versus preformed silo 6%; P=0.5),
suggesting that this observed trend did not have a sustained
clinically important effect (that is, they had self limiting
intestinal failure), although as the numbers involved are small
this possibility cannot be excluded completely. Infants in the
preformed silo group had a tendency to require longer stays in
hospital. There were no other significant differences between
the groups. It remains important to note, however, that this is
an observational study and not a randomised controlled trial;
therefore it is likely that individual characteristics of patients
that we have not captured and the preferences of surgeons
influenced the choice of initial surgical strategy and its
subsequentsuccess,andhencetheresultsshouldbeviewedwith
appropriate caution. The three neonatal deaths from ischaemic
bowel in infants with simple gastroschisis managed initially
with a preformed silo provide a clear reminder that silos do not
eliminatetheriskoftorsionofthebowelorinadequateintestinal
perfusion, emphasising the importance of appropriate case
selection for this type of treatment.
Strengths and weaknesses of the study
This study provides a comprehensive assessment of outcomes
at1yearforanationalcohortofinfantswithgastroschisis.This
was achieved through a collaboration of all tertiary paediatric
surgical centres in the UK and Ireland, which enabled initial
data to be collected on all cases nationally with follow-up at 1
year, providing a representative sample of recently treated
infants with outcome data beyond the initial perioperative
period. Follow-up to 1 year was undertaken to ensure we
identified all “late” mortality,organtransplantation,or ongoing
dependency on parenteral nutrition. Additional sources were
usedtosafeguardthecompletenessofthisnationalcohort.
21We
have complete data, however, for only 75% of infants at 1 year
of age, and, although the group without follow-up data seems
comparablewiththosewefollowedup,andthereforesystematic
bias as a consequence of this incomplete follow-up is unlikely,
we cannot exclude the possibility that the study results could
differ if we had 1 year data on all infants.
The population based nature of the study means that the data
presented are an accurate description of outcomes for current
surgical management strategies in the UK. The data are free
from the case selection and information biases inherent in
retrospective single centre series, which necessitate cases to be
collected over prolonged periods to gain adequate numbers and
as such are a blunt tool with which to study contemporary
management of rare congenital anomalies. In this study, the
responsibility for reporting cases and collecting data lay with
the surgeons caring for the infants and did not rely on data
collected “second hand” from administrative databases, which
are not usually population based, are unable to determine the
temporal relation between events and hence causality, and are
reliantonaccuratediagnosticcoding,whichisoftencarriedout
by clerks rather than the clinician responsible for providing
care.
31 The outcome data in this study are nationally
representativeandcanthusbeusedasbenchmarkagainstwhich
practice and outcomes in single centres can be compared and
future innovations in practice or service provision measured.
Aswehavenotedabove,however,thisisanobservationalstudy
and not a randomised trial, and it is therefore possible that
uncontrolled confounding, such as from other factors involved
in surgical decision making, could account for some of the
differences we observed.
Comparison with other studies
We used the classification proposed by Molik et al to divide
casesinto“simple”and“complex”groupsbasedonthepresence
or absence of intestinal atresia, perforation, or necrosis at
deliveryorpresentation.
14Thisclassificationhasbeenvalidated
with US national inpatient databases and shown to predict
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RESEARCHsurvival and use of resources.
32 The only other national
prospective population based study examining outcomes in
gastroschisis did not apply any form of risk stratification,
perhaps because of the lower number of cases enrolled.
10 In our
data, 87% and 11% of cases were classified as simple and
complex, respectively, in keeping with previous studies.
11
Our findings support the use of the classification of Molik et al
as a simple, immediately available prognostic tool, which
reliably identifies two subgroups of patients with divergent
outcomes and postnatal courses. It did not, however, predict
case fatality, although with such a low event rate and disparate
range of causes of death this is perhaps not surprising. Other
scoringsystemshavebeensuccessfullyappliedtopatientswith
gastroschisis to predict outcome. The score for neonatal acute
physiology-II (SNAP-II) predicts mortality and other survival
variables
33 but relies on the collection of several physiological
variables. A risk stratification index, developed and validated
on two US hospital databases, used logistic regression analysis
to identify four coexisting conditions—intestinal atresia,
necrotising enterocolitis, lung hypoplasia, and cardiac
anomalies—which predict use of resources and mortality.
12
Although the authors report a greater ability to discriminate
between low and high risk patients using the index, the rarity
of lung hypoplasia (0.4%) and cardiac malformations (8.7%)
limit the ability of the index to discriminate between outcomes
for most cases of gastroschisis, which do not have these
associated anomalies. The onset of necrotising enterocolitis,
whichtypically occurslateinaninfant’s clinicalcourse, further
limitstheefficacyoftheindexasanearlypredictorofoutcome.
The time to full tolerance of enteral feeding is an important
outcome measure as it determines the duration of parenteral
nutrition and hence the risk of complications, including central
line sepsis, hepatic dysfunction associated with parenteral
nutrition, and liver transplant.
34 The intestinal failure working
group of the British Society of Paediatric Gastroenterology,
Hepatology and Nutrition and the British Association of
Paediatric Surgeons define intestinal failure as a requirement
for parenteral nutrition exceeding 28 days.
30 A Centers for
Disease Control analysis in the United States and a population
based study in Canada reported mean parenteral nutrition
requirements of 28 and 29 days, respectively.
6 10 In our study,
81%and41%ofinfantswithcomplexandsimplegastroschisis,
respectively, had a requirement for parenteral nutrition
exceeding28days.Overaquarterofinfantsmeetingthecriteria
for intestinal failure in the complex group progressed to liver
disease associated with intestinal failure compared with less
than half in the simple group.
To date one multicentre randomised controlled trial compared
outcomes for preformed silos and primary operative primary
fascialclosureeitheronthewardorundergeneralanaesthesia.
35
This study randomised 55 of 195 infants eligible for inclusion
at three centres. There was no difference between the groups in
any outcome variable examined including duration of
ventilation, parenteral nutrition, and stay in hospital or the
incidenceofsepsisandnecrotisingenterocolitis.Theonlyother
population based study to date found a significant reduction in
length of stay and duration of parenteral nutrition in infants
managedwith“urgent[primaryfascial]closure”comparedwith
initial application of a preformed silo, although the surgical
strategy and perinatal management were not standardised.
27
After multivariate logistic regression, the Canadian Pediatric
Surgery Network (CAPSNET) group concluded that the
techniques of abdominal wall closure are not associated with
functional outcomes in infants with gastroschisis. The key
predictor of an adverse outcome was failure to achieve
successful fascial closure by whichever method was initially
used.
10 Current evidence suggests that in the absence of clear
clinically relevant benefit with either technique, there is still a
need for an adequately powered multicentre randomised
controlledtrialofapplicationofapreformedsiloversusprimary
operative primary fascial closure.
Conclusions
This study provides a comprehensive picture of current UK
practice and outcomes that will inform and enhance the
processesofantenatalcounsellingandpostnatalprognosis.The
outcome data provide a national benchmark against which
individual centres can assess their own performance. The
classification of gastroschisis into simple and complex groups,
as defined by Molik et al,
14 provides a pragmatic readily
available method of risk stratification that we have now shown
can predict outcome on a population based level. There is,
however, a place for future work to define the relative
indicationsfortheuseofprimaryfascialclosureandpreformed
silos. A multicentre randomised controlled trial is the next
logical step to compare operative primary fascial closure with
applicationofapreformedsiloininfantssuitableatpresentation
for either type of treatment to determine the optimal initial
management strategy and define algorithms of care.
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RESEARCHWhat is already known on this topic
The worldwide birth prevalence of gastroschisis is increasing, with considerable economic and resource implications for healthcare
providers
Gastroschisis has been transformed from a uniformly fatal condition to one with survival rates exceeding 90%, prompting research
directed at risk stratification to predict outcome
What this study adds
This population based cohort study of gastroschisis provides representative “benchmark” 1 year outcome data on a national basis
This study validates the classification of gastroschisis into simple and complex subgroups that predict length of stay in hospital, duration
of parenteral nutrition, and risk of late complications
The lack of clinically relevant differences in most outcome measures between neonates managed with operative primary fascial closure
or application of a preformed silo confirms the position of equipoise required for a national randomised controlled trial
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Table 1| Characteristics of infants with gastroschisis according to duration of follow-up. Figures are percentages* (numbers) of infants
P value Initial data only (n=92) Follow-up to age 1 year (n=301†) Characteristic
Ethnicity:
0.9 91 (79) 91 (264) White
9 (8) 9 (25) Non-white
Sex:
0.5 42 (39) 46 (138) Male
58 (53) 54 (162) Female
Birth weight (g):
0.6 43 (40) 41 (121) ≥2500
57 (52) 59 (177) <2500
Gestational age (weeks):
0.6 57 (52) 53 (159) ≥37
43 (40) 47 (139) <37
0.8 99 (91) 99 (294) Antenatally diagnosed
0.8 7 (6) 6 (17) Associated anomalies (non-bowel)
Type of delivery:
0.4 13 (12) 14 (41) Caesarean before labour
20 (18) 27 (80) Caesarean after onset of labour
67 (61) 59 (177) Other
<0.001 20 (18) 40 (119) Transferred after birth
Type of gastroschisis:
0.1 5 (5) 2 (7) Unknown
15 (14) 11 (32) Complex
79 (73) 87 (262) Simple
Initial surgical management:
0.1 59 (54) 46 (139) Operative fascial closure
28 (26) 37 (112) Preformed silo
13 (12) 17 (50) Other
Received parenteral nutrition‡:
0.7 53 (47) 55 (158) <28 days
47 (41) 44 (127) ≥28 days
*Percentages of those with data.
†Includes 12 infants who died in first year of life.
‡Excludes 6 infants who died in neonatal period.
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RESEARCHTable 2| Outcomes in infants with simple or complex gastroschisis*. Figures are percentages* (numbers) of infants
P value Relative risk (95% CI) Complex (n=31) Simple (n=251)
0.001 5.13 (2.15 to 12.3) 23 (7) 4 (11) Liver disease associated with intestinal
failure
<0.001 4.39 (2.50 to 7.70) 42 (13) 10 (24) Required unplanned reoperation
Unplanned reoperations by indication for surgery†:
0.02 8.10 (1.71 to 38.4) 10 (3) 1 (3) Ischaemic bowel
0.2 8.09 (0.52 to 126.2) 3 (1) 0.4 (1) Necrotising enterocolitis
0.06 3.23 (1.08 to 9.71) 13 (4) 4 (10) Adhesional small bowel obstruction
1.0 0 (0 to 43.6) 0 (0) 1 (2) Infective complication
0.01 12.1 (2.11 to 69.9) 10 (3) 1 (2) Anastomotic stricture
0.1 ∞ (0.21 to ∞) 3 (1) 0 (0) Complications related to stoma
1.0 0 (0 to 20.0) 0 (0) 1 (3) Silo related
0.1 ∞ (0.21 to ∞) 3 (1) 0 (0) Bowel lengthening procedure
0.1 ∞ (0.21 to ∞) 3 (1) 0 (0) Liver transplantation
0.03 16.2 (1.51 to 173.5) 6 (2) 0.5 (1) Other unplanned laparotomy
0.09 3.47 (0.95 to 12.7) 10 (3) 3 (7) Other unplanned operation
<0.001 1.96 (1.56 to 2.46) 81 (25) 41 (102) Parenteral nutrition >28 days‡
Days to discharge§:
<0.001 — 7 (2) 37 (91) <30
27 (8) 35 (85) 31-59
67 (20) 28 (68) ≥60
*In seven cases there was insufficient information to enable classification into complex or simple; these cases have been excluded.
†Some infants required more than one unplanned reoperation.
‡Includes two infants who had not attained full enteral feeding at one year. Median time (days) to full enteral feeding (excluding infants who died in neonatal period)
was 24 (interquartile range 17-39, range 3->365) in infants with simple gastroschisis and 47 (30-83, range 15-297) in infants with complex gastroschisis (P<0.001).
§Excludes all infants who died.
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RESEARCHTable 3| Outcomes in infants with simple gastroschisis according to initial management. Figures are percentages (numbers) of infants
P value Risk ratio (95% CI)
Preformed silo group
(n=99)
Operative primary fascial
closure group (n=120)
0.8 1.22 (0.36 to 4.11) 5 (5) 4 (5) Liver disease associated with intestinal
failure
0.4 0.61 (0.25 to 1.44) 7 (7) 12 (14) Required unplanned re-operation
Unplanned reoperations by indication for surgery*:
1.0 0.61 (0.06 to 6.59) 1 (1) 2 (2) Ischaemic bowel
— — 0 (0) 0 (0) Necrotising enterocolitis
0.5 0.61 (0.15 to 2.36) 3 (3) 5 (6) Adhesional small bowel obstruction
0.5 — 0 (0) 2 (2) Infective complication
0.5 — 1 (1) 0 (0) Anastomotic stricture
— — 0 (0) 0 (0) Complications related to stoma
1.0 1.21 (0.08 to 19.1) 1 (1) 1 (1) Silo related
— — 0 (0) 0 (0) Bowel lengthening procedure
— — 0 (0) 0 (0) Liver transplantation
0.5 — 1 (1) 0 (0) Other unplanned laparotomy
0.7 1.62 (0.37 to 7.05) 4 (4) 3 (3) Other unplanned operation
0.004 1.61 (1.17 to 2.24) 52 (50) 32 (38) Parenteral nutrition >28 days†
Days to discharge‡:
0.03 — 28 (27) 46 (53) <30
40 (38) 30 (35) 31-59
32 (31) 24 (28) ≥60
*Some infants required more than one unplanned re-operation.
†Excludes six infants who died in neonatal period. Median time (days) to full enteral feeding (including two infants in operative primary fascial closure group and
one in preformed silo group who had not attained full enteral feeding at one year) was 22 (interquartile range 15-37, range 3->365) and 28 (20-49, range 7->365),
respectively, P=0.02.
‡Excludes all infants who died before age 1 year.
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Case reporting and completeness of 1 year follow-up in infants with gastroschisis
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